Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $5.9300 (0.51%) ($5.6000 - $6.2320) on Wed. Aug. 26, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.29% (three month average) | RSI | 56 | Latest Price | $5.9300(0.51%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -3.8% a day on average for past five trading days. | Weekly Trend | ANPC advances 0.4% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) IPO(10%) XLB(10%) LIT(9%) TLT(8%) OIH(7%) | Factors Impacting ANPC price | ANPC will decline at least -4.145% in a week (0% probabilities). SHY(-28%) XLU(-11%) IBB(-9%) XBI(-8%) TBT(-8%) | | | | | Relative Volatility | | | | Market Trend Strength | -4.145% (StdDev 8.29%) | Hourly BBV | -0.7 () | Intraday Trend | 0% | | | |
|
Resistance Level | $6.46 | 5 Day Moving Average | $6.32(-6.17%) | 10 Day Moving Average | $6.73(-11.89%) | 20 Day Moving Average | $6.46(-8.2%) | To recent high | -24.5% | To recent low | 16.5% | Market Cap | $51m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |